Post by Vanderbilt University Medical Center

No two patients experience cancer the same way, and no two cancers are exactly alike. That is why personalized approaches to treatment are becoming increasingly important. In this Q&A, Dr. Ben Park, director of Vanderbilt‑Ingram Cancer Center, shares how precision oncology is helping tailor cancer care by analyzing the genetic makeup of a tumor, including DNA and RNA. By better understanding what drives each individual cancer, clinicians can more precisely target treatment and, in some cases, even determine when less treatment may be needed. Read the full conversation to learn how genetics is shaping the future of cancer care: https://bit.ly/4sFIWzJ